Integrative pan-cancer genomics reveals immune-inflammatory associations of FES and its potential therapeutic relevance in gastric cancer
IntroductionFES encodes a non‐receptor tyrosine kinase with context‐dependent functions in cancer; however, its cross‐cancer genomic landscape, immune microenvironmental relevance, and therapeutic implications remain incompletely defined.